Alan Fournier (Trades, Portfolio) manages Pennant Master Fund, Pennant Windward Master Fund, Broadway Gate Master Fund Ltd. and Pennant General Partner LLC. He manages a portfolio composed of 38 holdings, and during the fourth quarter he raised his stake in six stocks and acquired two new positions.
Fournier acquired 7,107,480 shares Kinder Morgan Inc. (KMI) with an impact of 2.7% on the portfolio.
The company along with its subsidiaries owns an interest in or operates approximately 80,000 miles of pipelines and 180 terminals.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10, with weak returns of ROE 0.89% and ROA 0.40% that are under performing 74% of the companies in the Global Oil & Gas Midstream industry. Financial strength has a rating of 5 out of 10 with a cash-to-debt of 0.01 that is below the industry median of 0.09
The company’s largest shareholder among the gurus is Warren Buffett (Trades, Portfolio) with 1.19% of outstanding shares, followed by David Tepper (Trades, Portfolio) with 0.42% and Paul Tudor Jones (Trades, Portfolio) with 0.01%.
The guru bought 3,027,480 shares of Pfizer Inc. (PFE) with an impact of 2.49% on the portfolio.
The company applies science and its resources to bring therapies to people that extend and improve their lives through the discovery, development and manufacture of healthcare products. During the third quarter revenues increased 16% operationally.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10, with easy returns of ROE 11.92% and ROA 5.01% that are outperforming 56% of the companies in the Global Drug Manufacturers - Major industry.
James Barrow (Trades, Portfolio) is the largest shareholder of the company among the gurus with 0.87% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.52%, T Rowe Price Equity Income Fund (Trades, Portfolio) with 0.24%, Lee Ainslie (Trades, Portfolio) with 0.18%, Diamond Hill Capital (Trades, Portfolio) with 0.17%, Jana Partners (Trades, Portfolio) with 0.15% and Vanguard Health Care Fund (Trades, Portfolio) with 0.14%.
Fournier raised his stake in Allergan PLCÂ (AGN) by 17.44% with an impact of 0.9% on the portfolio.
The company is engaged in the development, manufacturing, marketing, sale and distribution of generic, branded generic, brand name, biosimilar and over-the-counter pharmaceutical products. In the fourth quarter, adjusted EBITDA from continuing operations increased 115%, and the company reported 33% growth in non-GAAP diluted EPS.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10, with easy returns of ROE 6.56% and ROA 3.62% that are outperforming 50% of the companies in the Global Drug Manufacturers - Specialty & Generic industry. Financial strength has a rating of 5 out of 10 with a cash-to-debt of 0.05 that is far below the industry median of 2.56.
The company’s largest shareholder among the gurus is Vanguard Health Care Fund (Trades, Portfolio) with 2.78% of outstanding shares, followed by Andreas Halvorsen (Trades, Portfolio) with 1.52%, John Paulson (Trades, Portfolio) with 1.4%, Daniel Loeb (Trades, Portfolio) with 1.37% and Paul Singer (Trades, Portfolio) with 0.51%.
The guru increased his stake in Molson Coors Brewing Co. (TAP) by 21.56% with an impact of 0.88% on the portfolio.
The company is a brewer with a portfolio of owned and partner brands, including core brands Carling, Coors Light, Molson Canadian & Staropramen, as well as craft and specialty beers such as Blue Moon, Creemore Springs, Cobra and Sharp's Doom Bar. Third quarter net sales decreased 12.9% on a reported basis and increased 0.7% in constant currency, and U.S. GAAP net income from continuing operations attributable to MCBC increased 138.4%.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10, with good returns of ROE 18.54% and ROA 10.42% that are underperforming 57% of the companies in the Global Beverages - Brewers industry. Financial strength has a rating of 8 out of 10 with a cash-to-debt ratio of 0.15 that is below the industry median of 0.43.
First Eagle Investment (Trades, Portfolio) is the largest shareholder of the company among the gurus, with 0.74% of outstanding shares followed by Steve Mandel (Trades, Portfolio) with 0.58%, Daniel Loeb (Trades, Portfolio) with 0.49%, Pioneer Investments (Trades, Portfolio) with 0.38%, Jim Simons (Trades, Portfolio) with 0.13%, Diamond Hill Capital (Trades, Portfolio) with 0.13% and Steven Cohen (Trades, Portfolio) with 0.09%.
Fournier raised his stake in United Continental Holdings Inc. (UAL) by 35.9% with an impact of 0.76% on the portfolio.
The company is a holding company and its principal, wholly owned subsidiary is United Airlines Inc.
GuruFocus gives the stock a profitability and growth rating of 5 out of 10, with strong returns of ROE 135.56% and ROA 15.56% that are over performing 96% of the companies in the Global Airlines industry. Financial strength has a rating of 7 out of 10 with a cash-to-debt of 0.44 that is few below the industry median of 0.46.
The company largest shareholder among the gurus is PRIMECAP Management (Trades, Portfolio) with 5.42% of outstanding shares followed by Sarah Ketterer (Trades, Portfolio) with 0.75%, Leon Cooperman (Trades, Portfolio) with 0.72%, Jim Simons (Trades, Portfolio) with 0.4% and Pioneer Investments (Trades, Portfolio) with 0.38%.
The guru increased his stake in Range Resources Corp. (RRC) by 43.38% with an impact of 0.65% on the portfolio.
The company is a Texas-based independent natural gas, natural gas liquids and oil company, engaged in the exploration, development and acquisition of natural gas and oil properties, mostly in the Appalachian and Southwestern regions of the U.S. Third quarter unit costs declined by 12% compared to the prior-year quarter, and Marcellus production had an increase of 27% over the prior-year quarter.
GuruFocus gives the stock a profitability and growth rating of 8 out of 10, with negative returns of ROE 3.57% and ROA 1.26% but that are outperforming 76% of the companies in the Global Oil & Gas E&P industry. Financial strength has a rating of 6 out of 10 with a cash-to-debt ratio of 0.37 that is below the industry median of 0.51.
Andreas Halvorsen (Trades, Portfolio) is the largest shareholder of the company among the gurus with 6.84% of outstanding shares, followed by Andreas Halvorsen (Trades, Portfolio) with 5.78%, Ruane Cunniff (Trades, Portfolio) with 3.49%, Wallace Weitz (Trades, Portfolio) with 1.9%, Jim Simons (Trades, Portfolio) with 1.21%, Hotchkis & Wiley with 1.07% and David Tepper (Trades, Portfolio) with 0.95%.
Fournier raised his stake in Delta Air Lines Inc. (DAL) by 19.92% with an impact of 0.35% on the portfolio.
The company provides scheduled air transportation for passengers and cargo throughout the U.S. and around the world. It operates in domestic and international markets. Fourth-quarter adjusted pre-tax income increased 42% year-over-year on a similar basis and adjusted net income grew 51% from the same quarter of a year before.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10, with strong returns of ROE 46.55% and ROA 8.47% that are outperforming 71% of the companies in the Global Airlines industry. Financial strength has a rating of 4 out of 10 with a cash-to-debt ratio of 0.41 that is few below the industry median of 0.46.
The company's largest shareholder among the gurus is PRIMECAP Management (Trades, Portfolio) with 2.38% of outstanding shares, followed by David Tepper (Trades, Portfolio) with 0.94%, First Eagle Investment (Trades, Portfolio) with 0.39%, Sarah Ketterer (Trades, Portfolio) with 0.39%, George Soros (Trades, Portfolio) with 0.25% and John Burbank (Trades, Portfolio) with 0.22%.
The guru increased his stake in Evolent Health Inc. (EVH) by 16.28% with an impact of 0.04% on the portfolio.
The company is engaged in providing health care delivery and payment services. It is a managed services firm that supports integrated health systems in their migration toward value-based care and population health management.
GuruFocus gives the stock a profitability and growth rating of 2 out of 10, but the company has strong returns of ROE 18.54% and ROA 10.42% that are outperforming 99% of the companies in the Global Health Information Services industry. Financial strength has a rating of 5 out of 10 with no debt.
Other notable shareholders of the company are Jim Simons (Trades, Portfolio) with 0.24% of outstanding shares followed by Paul Tudor Jones (Trades, Portfolio) with 0.03%.
